发明名称 |
Methods and therapies for treating inflammatory conditions with exposed collagen |
摘要 |
Compositions and methods for treating and imaging vulnerable plaque and other inflammatory conditions in a patient rely on the delivery of conversion electron-emitting sources and other radionuclides to regions of exposed collagen in the vasculature or other body lumens. The conversion electron-emitting sources or other radionuclides are coupled to a collagen-binding substance and administered to the vasculature or other body lumen to permit binding for imaging and/or therapeutic purposes. |
申请公布号 |
US9623129(B2) |
申请公布日期 |
2017.04.18 |
申请号 |
US200611534847 |
申请日期 |
2006.09.25 |
申请人 |
SnIP Holdings, Inc. |
发明人 |
Gonzales Gilbert R.;DeVore Dale;Srivastava Suresh |
分类号 |
A61K51/00;A61M36/14;A61K51/10 |
主分类号 |
A61K51/00 |
代理机构 |
Wood Herron & Evans LLP |
代理人 |
Wood Herron & Evans LLP |
主权项 |
1. A method of treating an inflammatory condition in a body lumen, said method comprising:
introducing to the body lumen a therapeutically effective amount of a collagen Type I and/or Type III binding substance bound to no-carrier-added tin-117m during a cascading rupture of vulnerable plaque;
wherein the binding substance specifically binds to Type I and/or Type III collagen exposed within the body lumen as a result of the rupture of vulnerable plaque and wherein the tin-117 m provides therapy to the vulnerable plaque. |
地址 |
The Woodlands TX US |